TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

53.61 -0.68 (-1.25%)

Delayed Quote Updated: 2:35 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TG Therapeutics, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

TG Therapeutics, Inc. (NASDAQ:TGTX) Investor Alert: Investigation over Potential Wrongdoing ↗

March 23, 2022

San Diego, CA -- (SBWIRE) -- 03/23/2022 -- Certain directors of TG Therapeutics, Inc are under investigation over potential breaches of fiduciary duties.

Via SBWire

Looking Into TG Therapeutics's Return On Capital Employed ↗

March 04, 2022

TG Therapeutics (NASDAQ:TGTX) brought in sales totaling $2.32 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 8.99%, resulting in a loss...

Via Benzinga

FDA Pushes TG Therapeutics' Ublituximab / Ukoniq Combo Therapy Applications In Blood Cancer Settings ↗

March 03, 2022

The FDA has extended the review period of TG Therapeutics Inc's (NASDAQ: TGTX) biologics license application and supplemental New Drug Application for...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates ↗

March 02, 2022

The Food and Drug Administration approval calendar was light in February. Nevertheless, the month saw regulatory nods accorded to some breakthrough therapies. Agios...

Via Benzinga

TG Therapeutics: Q4 Earnings Insights ↗

March 01, 2022

TG Therapeutics (NASDAQ:TGTX) reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

Earnings Scheduled For March 1, 2022 ↗

March 01, 2022

Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...

Via Benzinga

TG Therapeutics Falls 30% As CEO Discloses Partial Clinical Hold On Blood Cancer Trials ↗

January 27, 2022

TG Therapeutics Inc's (NASDAQ: TGTX) CEO Michael Weiss said that the FDA has

Via Benzinga

Where TG Therapeutics Stands With Analysts ↗

January 24, 2022

Within the last quarter, TG Therapeutics (NASDAQ:TGTX) has observed the fol...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 15, 2022

During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by...

Via Benzinga

Global Multiple Sclerosis Drugs Market Expected to Reach $41.99 Billion in 2028

February 03, 2022

Palm Beach, FL –– February 3, 2022 – FinancialNewsMedia.com News Commentary – Multiple Sclerosis (MS) is an immune-mediated disease of the central nervous system. It is characterized by demyelination,...

Via FinancialNewsMedia

Massive Month-End Buying of Biggest Losers ↗

January 31, 2022

The average stock in the Russell 3,000 is now up 7% from the index’s low point last Friday as we near the final close of January 2022.

Via Talk Markets

64 Biggest Movers From Yesterday ↗

January 28, 2022

Check out these penny stocks insiders are buying Losers ION Geophysical Corporation (NYSE: IO) shares fell 53.6% to settle at $0.51 on Thursday. Epizyme, Inc. (NASDAQ:...

Via Benzinga

52 Biggest Movers From Friday ↗

January 31, 2022

Gainers Knightscope, Inc. (NASDAQ: KSCP) surged 175.6% to close at $3.40 on Friday. The company, on Thursday, priced its IPO at $10 per share. Imperial Petroleum Inc. (NASDAQ:...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 27, 2022

Gainers Galapagos (NASDAQ:GLPG) stock rose 21.4% to $64.75 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 1.5 million, which is...

Via Benzinga

46 Stocks Moving In Thursday's Mid-Day Session ↗

January 27, 2022

Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 158.2% to $7.23 after tumbling 18% on Wednesday. Indonesia Energy said it projects to commence drilling...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

January 24, 2022

SVB Leerink cut Biogen Inc. (NASDAQ:BIIB) price ...

Via Benzinga

TG Therapeutics, Inc. (NASDAQ:TGTX) Investor Notice: Investigation over Possible Violations of Securities Laws ↗

January 20, 2022

San Diego, CA -- (SBWIRE) -- 01/20/2022 -- TG Therapeutics, Inc is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

NASDAQ:TGTX Investor Notice: Investigation over Possible Securities Laws Violations by TG Therapeutics, Inc. ↗

January 19, 2022

San Diego, CA -- (SBWIRE) -- 01/19/2022 -- An investigation was announced concerning potential securities laws violations by TG Therapeutics, Inc. in connection with certain financial statements.

Via SBWire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 05, 2022

Gainers SomaLogic (NASDAQ:SLGC) shares mo...

Via Benzinga

63 Biggest Movers From Friday ↗

December 20, 2021

Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...

Via Benzinga

TG THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating TG Therapeutics, Inc. on Behalf of TG Therapeutics Stockholders and Encourages Investors to Contact the Firm

December 03, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

10 Biggest Price Target Changes For Wednesday ↗

December 01, 2021

Morgan Stanley boosted Zscaler, Inc. (NASDAQ: ZS) price target from $275 to $330. Zscaler shares rose 7.1% to $371.50 in pre-market trading. Citigroup boosted Applied...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 30, 2021

Gainers Cumberland (NASDAQ:CPIX) stock...

Via Benzinga

Mid-Afternoon Market Update: Dow Dips 500 Points; ImmunoGen Shares Spike Higher ↗

November 30, 2021

Toward the end of trading Tuesday, the Dow traded down 1.44% to 34,628.69 while the NASDAQ fell 1.34% to 15,571.16. The S&P also fell, dropping 1.36% to 4,592.03. The U.S. has...

Via Benzinga

Topics Stocks

52 Biggest Movers From Yesterday ↗

December 01, 2021

Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares climbed 128.6% to close at $5.03 on Tuesday. The FDA approved expanded labeling for Cumberland...

Via Benzinga

TG Therapeutics Shares Plunge After FDA Plans AdComm Meet For Blood Cancer Candidate ↗

November 30, 2021

TG Therapeutics Inc (NASDAQ: TGTX) shares are falling after FDA notified the Company that it plans to host an Oncologic Drugs Advisory Committee (ODAC) meeting for marketing...

Via Benzinga

Mid-Day Market Update: Barnes & Noble Education Drops Following Q2 Results; Cumberland Pharmaceuticals Shares Jump ↗

November 30, 2021

Midway through trading Tuesday, the Dow traded down 0.88% to 34,827.81 while the NASDAQ fell 0.78% to 15,659.31. The S&P also fell, dropping 0.3832% to 4,616.53. The U....

Via Benzinga

Topics Stocks

35 Stocks Moving In Tuesday's Mid-Day Session ↗

November 30, 2021

Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares jumped 105.9% to $4.53. The FDA approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an...

Via Benzinga

Why TG Therapeutics Stock Is Falling Today ↗

November 30, 2021

TG Therapeutics Inc (NASDAQ: TGTX) is trading lower Tuesday after the company reported the U.S. Food and Drug Administration plans to host a meeting of the Oncologic...

Via Benzinga

Mid-Morning Market Update: Markets Mostly Lower; JinkoSolar Issues Weak Sales Forecast ↗

November 30, 2021

Following the market opening Tuesday, the Dow traded down 0.60% to 34,923.74 while the NASDAQ climbed 0.16% to 15,807.66. The S&P also fell, dropping 0.32% to 4,640.44...

Via Benzinga

Topics Stocks

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.